Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Return on Equity (2016 - 2025)

Historic Return on Equity for Medifast (MED) over the last 15 years, with Q4 2025 value amounting to 0.09%.

  • Medifast's Return on Equity fell 1000.0% to 0.09% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.09%, marking a year-over-year decrease of 1000.0%. This contributed to the annual value of 0.09% for FY2025, which is 1000.0% down from last year.
  • As of Q4 2025, Medifast's Return on Equity stood at 0.09%, which was down 1000.0% from 0.0% recorded in Q3 2025.
  • Over the past 5 years, Medifast's Return on Equity peaked at 1.08% during Q3 2022, and registered a low of 0.09% during Q4 2025.
  • For the 5-year period, Medifast's Return on Equity averaged around 0.5%, with its median value being 0.69% (2023).
  • In the last 5 years, Medifast's Return on Equity soared by 2700bps in 2022 and then crashed by -6000bps in 2024.
  • Quarter analysis of 5 years shows Medifast's Return on Equity stood at 0.82% in 2021, then rose by 14bps to 0.94% in 2022, then crashed by -46bps to 0.5% in 2023, then tumbled by -98bps to 0.01% in 2024, then crashed by -1014bps to 0.09% in 2025.
  • Its Return on Equity was 0.09% in Q4 2025, compared to 0.0% in Q3 2025 and 0.02% in Q2 2025.